UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's ...

People taking drugs for HIV and hepatitis B are less likely to develop Alzheimer’s disease, according to a new study. UVA Health investigators now would like clinical trials to examine the potential ...

The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers believe.

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases ...